Variant report
Variant | nsv963959 |
---|---|
Chromosome Location | chr2:77889494-77901733 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:19)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:19 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:77893819-77894063 | HepG2 | liver: | n/a | chr2:77893930-77893941 |
2 | CEBPB | chr2:77893764-77894088 | HepG2 | liver: | n/a | chr2:77893930-77893941 |
3 | CEBPB | chr2:77893984-77894002 | A549 | lung: | n/a | n/a |
4 | CTCF | chr2:77894725-77894782 | GM10266 | blood: | n/a | n/a |
5 | EP300 | chr2:77893717-77894171 | HepG2 | liver: | n/a | n/a |
6 | EP300 | chr2:77893873-77893901 | HepG2 | liver: | n/a | n/a |
7 | EP300 | chr2:77893798-77894107 | HepG2 | liver: | n/a | n/a |
8 | FOSL2 | chr2:77893830-77894142 | HepG2 | liver: | n/a | n/a |
9 | FOXA1 | chr2:77893691-77894101 | HepG2 | liver: | n/a | n/a |
10 | FOXA1 | chr2:77893629-77894136 | HepG2 | liver: | n/a | n/a |
11 | FOXA1 | chr2:77893740-77894142 | HepG2 | liver: | n/a | n/a |
12 | FOXA2 | chr2:77893722-77894056 | HepG2 | liver: | n/a | n/a |
13 | MYBL2 | chr2:77893672-77894149 | HepG2 | liver: | n/a | n/a |
14 | NR3C1 | chr2:77890898-77891070 | A549 | lung: | n/a | n/a |
15 | POLR2A | chr2:77896417-77896425 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr2:77895586-77895634 | GM12878 | blood: | n/a | n/a |
17 | POLR2A | chr2:77898778-77898888 | GM12878 | blood: | n/a | n/a |
18 | POLR2A | chr2:77897513-77897694 | GM12878 | blood: | n/a | n/a |
19 | REST | chr2:77891018-77891062 | GM12878 | blood: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-REG3G-5 | chr2:77900177-77900918 | XLOC_001541 |
2 | lnc-REG3G-5 | chr2:77899341-77899395 | XLOC_001541 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000230968 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561419046 | chr2:77892012-77892013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573319333 | chr2:77892020-77892021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535938513 | chr2:77892021-77892022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181337346 | chr2:77892022-77892023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148355464 | chr2:77892079-77892080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186863616 | chr2:77892103-77892104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576144601 | chr2:77892132-77892133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545231895 | chr2:77892137-77892138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565177171 | chr2:77892142-77892143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144752434 | chr2:77892153-77892154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371222743 | chr2:77892173-77892174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561236476 | chr2:77892195-77892196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530132455 | chr2:77892199-77892200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528874614 | chr2:77892200-77892201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116547684 | chr2:77892220-77892221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563845014 | chr2:77892229-77892230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532593391 | chr2:77892238-77892239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148539364 | chr2:77892248-77892249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537176113 | chr2:77892266-77892267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534953381 | chr2:77892416-77892417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533125319 | chr2:77892458-77892459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557031823 | chr2:77892461-77892462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191712543 | chr2:77892499-77892500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555980006 | chr2:77892550-77892551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111497952 | chr2:77892559-77892560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187917542 | chr2:77892575-77892576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538221662 | chr2:77892579-77892580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551646303 | chr2:77892586-77892587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538360147 | chr2:77892602-77892603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4513323 | chr2:77892612-77892613 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs189701990 | chr2:77892625-77892626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541307913 | chr2:77892640-77892641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537220281 | chr2:77892672-77892673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75786480 | chr2:77892698-77892699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182055756 | chr2:77892711-77892712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186691090 | chr2:77892720-77892721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539627140 | chr2:77892764-77892765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs114393993 | chr2:77892768-77892769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142851916 | chr2:77892776-77892777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549513030 | chr2:77892787-77892788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192854631 | chr2:77892824-77892825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528688860 | chr2:77892825-77892826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548457937 | chr2:77892838-77892839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184883259 | chr2:77892874-77892875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs188594631 | chr2:77892875-77892876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549705496 | chr2:77892917-77892918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150616868 | chr2:77892923-77892924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538707310 | chr2:77892934-77892935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552843795 | chr2:77892952-77892953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558712104 | chr2:77892956-77892957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Epilepsy | 22083797 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77892000-77893800 | Enhancers | Fetal Lung | lung |
2 | chr2:77892200-77894200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr2:77892800-77894000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr2:77893200-77894200 | Enhancers | HepG2 | liver |
5 | chr2:77893600-77894200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |